Imaging Study to Investigate Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence (SPOTLIGHT)

Condition:   Prostate Cancer Intervention:   Drug: rhPSMA-7.3 (18F) Injection Sponsors:   Blue Earth Diagnostics;   Parexel Not yet recruiting
Source: - Category: Research Source Type: clinical trials

Related Links:

Publication date: Available online 17 January 2020Source: European UrologyAuthor(s): Trevor C. Hunt, Brock B. O’Neil
Source: European Urology - Category: Urology & Nephrology Source Type: research
Authors: Rodríguez Cabello MÁ, Sanz Migueláñez JL, Méndez Rubio S, Arias Fúnez F, Garrido Abad P, Carrillo Guivernau MJ, Velasco Ruíz M, González Gordaliza C, Platas Sancho A Abstract INTRODUCTION: Prostate Fusion biopsy (MRI + prostate ultrasound) is described in literature as superior to classic random transrectal biopsy in order to identify suspicious lesion. OBJECTIVES: To evaluate the Prostate Imaging Reporting and Data System (PI-RADS) proposed by the European Society of Urogenital Radiology (ESUR) for detection of prostate cancer by multiparametric ...
Source: Archivos Espanoles de Urologia - Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
PROSTATE cancer is killing our men. The death toll for this deadly disease has hit an all-time high and recognising symptoms might save your life.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Molecules, Vol. 25, Pages 398: γ-Tocotrienol and α-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells Molecules doi: 10.3390/molecules25020398 Authors: Spencer Asay Andrew Graham Sydney Hollingsworth Bradley Barnes Richard V. Oblad David J. Michaelis Jason D. Kenealey Prostate cancer is the second most commonly diagnosed cancer in men, and metastatic prostate cancer is currently incurable. Prostate cancer frequently becomes resistant to standard of care treatments, and the administration of chemotherapeutic drugs is often accompanied by toxic side eff...
Source: Molecules - Category: Chemistry Authors: Tags: Article Source Type: research
AbstractPurposeThanks to the introduction of more sensitive/specific imaging and minimally invasive treatment techniques, the oligometastatic state in prostate cancer (PCa) has attracted the interest of the uro-oncological community. We aim to identify and analyze trials across five registries to gain insights into the directions this field is moving.MethodsA systematic review of trials on oligometastatic PCa registered on, ANZCTR, ISRCTN, Netherlands and UMIN Clinical Trials Registries was performed using the following keywords: ‘prostate cancer’ and ‘oligo’. Data were extracted ...
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
Title: AI Might Help Spot, Evaluate Prostate CancerCategory: Health NewsCreated: 1/16/2020 12:00:00 AMLast Editorial Review: 1/17/2020 12:00:00 AM
Source: MedicineNet Cancer General - Category: Cancer & Oncology Source Type: news
Publication date: Available online 16 January 2020Source: Molecular Aspects of MedicineAuthor(s): Delila Gasi Tandefelt, Johann de BonoAbstractOnly in the past decade tremendous advances have been made in understanding prostate cancer genomics and consequently in applying new treatment strategies. As options regarding treatments are increasing so are the challenges in selecting the right treatment option for each patient and not the least, understanding the optimal time-point and sequence of applying available treatments. Critically, without reliable methods that enable sequential monitoring of evolving genotypes in indivi...
Source: Molecular Aspects of Medicine - Category: Molecular Biology Source Type: research
Prostate Cancer and Prostatic Diseases, Published online: 17 January 2020; doi:10.1038/s41391-020-0205-7A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI–US fusion biopsy for prostate-cancer detection
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research
To identify variables that predict persistent hypogonadism and castration in patients with prostate cancer (PCa) treated with brachytherapy (BT).
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Prostate Cancer | Research | Study